| Primary information |
|---|
| ID | 11060 |
| Uniprot ID | P62328 |
| Description | Thymosin beta-4 (T beta 4) (Fx) [Cleaved into- - Hematopoietic systemregulatory peptide (Seraspenide)]. |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Cytoplasm |
| Developmental Stage | NA |
| Similarity | Belongs to the thymosin beta family. |
| Tissue Specificity | Expressed in several hemopoietic cell lines and lymphoid malignant cells. Decreased levels in myeloma cells |
| Post Translational Modification | NA |
| Function | Seraspenide inhibits the entry of hematopoeitic pluripotent stem cells into the S-phase |
| Length | 44 |
| Molecular Weight | 5053 |
| Name | Hematopoietic system regulatory peptide |
| Sequence | SDKP |
| Sequence map | 4 (2-5) |
| PDB ID | 1UY5 |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|